Robeco Institutional Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Robeco Institutional Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-668	Closed	-$203K	–	889
2025 Q4	$203K	Hold	668	–	–	﹤0.01%	818
2025 Q3	$228K	Buy	+668	New	+$203K	﹤0.01%	840
2024 Q1	–	Sell	-668	Closed	-$120K	–	1115
2023 Q4	$120K	Sell	668 -5,260	-89%	-$952K	﹤0.01%	933
2023 Q3	$1.07M	Sell	5,928 -12,118	-67%	-$2.4M	﹤0.01%	773
2023 Q2	$3.22M	Hold	18,046	–	–	0.01%	619
2023 Q1	$3.89M	Buy	18,046 +4,402	+32%	+$1.06M	0.01%	599
2022 Q4	$3M	Buy	+13,644	New	+$2.5M	0.01%	645
2018 Q4	–	Sell	-12,302	Closed	-$2.12M	–	1006
2018 Q3	$2.12M	Buy	+12,302	New	+$2.07M	0.01%	682

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Robeco Institutional Asset Management's ONC Position: Q1 2026 in Review

Robeco Institutional Asset Management sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 668 shares — an estimated $203K sold.

Robeco Institutional Asset Management first reported a position in ONC in Q3 2018 and held it in 8 quarters. The position peaked at $3.89M in Q1 2023. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Robeco Institutional Asset Management reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
Robeco Institutional Asset Management sold 668 BeOne Medicines Ltd shares in Q1 2026, an estimated $203K.
Robeco Institutional Asset Management first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 8 quarters.
Robeco Institutional Asset Management's BeOne Medicines Ltd position peaked at $3.89M in Q1 2023.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.